Stay updated with breaking news from Frank van haren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A widely available and affordable blood-thinning drug, heparin, limits lung damage when inhaled by Covid-19 patients, and may also prevent infection from the SARS-CoV-2 virus, according to early results of a study. Researchers from the Australian National University (ANU) and colleagues are tracking hospital patients infected with SARS-CoV-2 in 13 countries who were given ....
Phico Therapeutics Ltd today announced that it has established a Science Advisory Board (SAB) to provide strategic scientific guidance to the Company. ....
A widely available and affordable drug, heparin, limits lung damage when inhaled by COVID-19 patients, according to world-first findings by researchers from The Australian National University (ANU). ....
Researchers from King s College London and the Australian National University found heparin - which costs around £33 per dose - improves oxygen levels by 70 per cent in virus patients. ....